| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 27, 2006
Accepted on September 26, 2007
B
From the Innovative Research Institute for Cell Therapy (H.-Y.L., S.-W.Y., J.-Y.K., K.-W.P., Y.-B.P., H.-S.K.), Seoul National University Hospital, the Department of Internal Medicine (H.-Y.L., S.-W.Y., K.-W.P., B.-H.O., Y.-B.P., H.-S.K.) and the Department of Biochemistry and Molecular Biology (C.-I.H., W.-Y.P., J.-S.S.), Seoul National University College of Medicine, Seoul, Korea; and the Whitaker Cardiovascular Institute (K.W.), Boston University School of Medicine, Boston, Mass.
* To whom correspondence should be addressed. E-mail: hyosoo{at}snu.ac.kr.
Objective—We evaluated the full range effects of FOXO3a in endothelial cells (ECs) by microarray analysis and investigated the role of FOXO3a regulating TNF receptor signaling pathway.
Methods and Results—Human umbilical vein endothelial cells (HUVECs) were transfected with adenoviral vectors expressing constitutively active FOXO3a (Ad-TM-FOXO3a). Ad-TM-FOXO3a transfection caused remarkable apoptosis, which were accompanied with upregulation of genes related with TNF receptor signaling, such as TNF-
, TANK (TRAF-associated NF-
B activator), and TTRAP (TRAF and TNF receptor-associated protein). Furthermore,
B-Ras1 (I
B-interacting Ras-like protein-1) which is known to block I
B degradation was found increased, and intranuclear translocation of NF-
B was inhibited. GADD45
and XIAP, negative regulators of c-Jun N-terminal kinase (JNK), were suppressed and JNK activity was increased. Attenuation of TNF signaling pathway either by blocking antibody for TNF receptor or by blocking JNK with DMAP (6-dimethylaminopurine) or Ad-TAM67 (dominant negative c-Jun) cotransfection, significantly reduced FOXO3a-induced apoptosis. Finally, treatment of vasculature with heat shock, an activator of endogenous FOXO3a, resulted in EC apoptosis, which was completely rescued by Ad-TAM67.
Conclusion—FOXO3a promotes apoptosis of ECs, through activation of JNK and suppression of NF-
B. These data identify a novel role of FOXO3a to turn TNF receptor signaling to a proapoptotic JNK-dependent pathway.
This article has been cited by other articles:
![]() |
B. Ding, N. C. Kirkiles-Smith, and J. S. Pober FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells J. Biol. Chem., July 17, 2009; 284(29): 19331 - 19339. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |